Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of ELDER PHARMA. For more details, see the ELDER PHARMA quarterly results and ELDER PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 5.0 |
No. of shares | m | 20.54 |
1 Week | % | 5.0 |
1 Month | % | 27.1 |
1 Year | % | -64.5 |
52 week H/L | Rs | 118.8/20.4 |
No. of Mths Year Ending |
12 Mar-10* |
12 Mar-11* |
12 Mar-12* |
12 Jun-13* |
12 Jun-14* |
5-Yr Chart Click to enlarge
|
---|
ELDER PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 383 | 440 | 435 | 474 | 380 | |
Low | Rs | 191 | 309 | 298 | 202 | 188 | |
Sales per share (Unadj.) | Rs | 379.1 | 465.2 | 644.9 | 793.4 | 489.2 | |
Earnings per share (Unadj.) | Rs | 25.0 | 30.9 | 35.2 | 40.1 | -3.2 | |
Diluted earnings per share | Rs | 23.0 | 30.9 | 35.2 | 40.1 | -3.2 | |
Cash flow per share (Unadj.) | Rs | 34.2 | 44.9 | 51.7 | 61.6 | 14.4 | |
Dividends per share (Unadj.) | Rs | 3.00 | 3.00 | 3.00 | 0 | 0 | |
Adj. dividends per share | Rs | 2.76 | 3.00 | 3.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 1.0 | 0.8 | 0.8 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 254.8 | 307.0 | 341.1 | 374.5 | 376.5 | |
Adj. book value per share | Rs | 234.0 | 307.1 | 341.1 | 374.6 | 376.6 | |
Shares outstanding (eoy) | m | 18.86 | 20.54 | 20.54 | 20.54 | 20.54 | |
Price / Sales ratio | x | 0.8 | 0.8 | 0.6 | 0.4 | 0.6 | |
Avg P/E ratio | x | 11.5 | 12.1 | 10.4 | 8.4 | -89.3 | |
P/CF ratio (eoy) | x | 8.4 | 8.3 | 7.1 | 5.5 | 19.7 | |
Price / Book Value ratio | x | 1.1 | 1.2 | 1.1 | 0.9 | 0.8 | |
Dividend payout | % | 12.0 | 9.7 | 8.5 | 0 | 0 | |
Avg Mkt Cap | Rs m | 5,412 | 7,693 | 7,527 | 6,943 | 5,832 | |
Total wages/salary | Rs m | 966 | 1,191 | 1,799 | 2,331 | 2,179 |
ELDER PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 7,149 | 9,555 | 13,245 | 16,296 | 10,048 | |
Other income | Rs m | 86 | 87 | 265 | 327 | 257 | |
Total revenues | Rs m | 7,235 | 9,642 | 13,511 | 16,623 | 10,305 | |
Gross profit | Rs m | 1,181 | 1,660 | 2,005 | 2,705 | 2,921 | |
Depreciation | Rs m | 172 | 287 | 340 | 441 | 361 | |
Interest | Rs m | 530 | 655 | 1,016 | 1,548 | 2,756 | |
Profit before tax | Rs m | 565 | 804 | 915 | 1,043 | 60 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 93 | 169 | 192 | 219 | 125 | |
Profit after tax | Rs m | 472 | 635 | 723 | 824 | -65 | |
Gross profit margin | % | 16.5 | 17.4 | 15.1 | 16.6 | 29.1 | |
Effective tax rate | % | 16.4 | 21.0 | 21.0 | 21.0 | 209.1 | |
Net profit margin | % | 6.6 | 6.7 | 5.5 | 5.1 | -0.6 |
ELDER PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 5,869 | 8,278 | 8,782 | 8,791 | 9,240 | |
Current liabilities | Rs m | 1,238 | 5,803 | 6,957 | 9,998 | 9,998 | |
Net working cap to sales | % | 64.8 | 25.9 | 13.8 | -7.4 | -7.5 | |
Current ratio | x | 4.7 | 1.4 | 1.3 | 0.9 | 0.9 | |
Inventory Days | Days | 34 | 68 | 67 | 146 | 128 | |
Debtors Days | Days | 997 | 1,079 | 941 | 892 | 602 | |
Net fixed assets | Rs m | 6,054 | 9,137 | 11,216 | 16,133 | 13,642 | |
Share capital | Rs m | 189 | 206 | 206 | 206 | 206 | |
"Free" reserves | Rs m | 4,616 | 6,101 | 6,800 | 7,487 | 7,528 | |
Net worth | Rs m | 4,805 | 6,307 | 7,006 | 7,693 | 7,733 | |
Long term debt | Rs m | 5,739 | 5,095 | 5,825 | 7,039 | 4,889 | |
Total assets | Rs m | 11,923 | 17,415 | 19,998 | 24,925 | 22,882 | |
Interest coverage | x | 2.1 | 2.2 | 1.9 | 1.7 | 1.0 | |
Debt to equity ratio | x | 1.2 | 0.8 | 0.8 | 0.9 | 0.6 | |
Sales to assets ratio | x | 0.6 | 0.5 | 0.7 | 0.7 | 0.4 | |
Return on assets | % | 8.4 | 7.4 | 8.7 | 9.5 | 11.8 | |
Return on equity | % | 9.8 | 10.1 | 10.3 | 10.7 | -0.8 | |
Return on capital | % | 10.4 | 12.8 | 15.0 | 17.6 | 22.3 | |
Exports to sales | % | 2.4 | 2.4 | 2.1 | 1.9 | 3.1 | |
Imports to sales | % | 4.2 | 3.7 | 2.3 | 1.8 | 0.4 | |
Exports (fob) | Rs m | 175 | 228 | 280 | 318 | 307 | |
Imports (cif) | Rs m | 298 | 351 | 306 | 290 | 43 | |
Fx inflow | Rs m | 175 | 228 | 280 | 318 | 307 | |
Fx outflow | Rs m | 345 | 388 | 334 | 361 | 125 | |
Net fx | Rs m | -170 | -160 | -54 | -43 | 181 |
ELDER PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -910 | 657 | 147 | 166 | 11,754 | |
From Investments | Rs m | -1,611 | -1,507 | -1,711 | -632 | -561 | |
From Financial Activity | Rs m | 1,843 | 2,734 | 433 | -39 | -6,762 | |
Net Cashflow | Rs m | -678 | 1,885 | 1,540 | 1,034 | 5,466 |
Share Holding
Shareholding as on Sep 2015
|
Company Information
|
CHM: Alok Jagdish Saxena | COMP SEC: Vijendra Jain | YEAR OF INC: 1983 | BSE CODE: 532322 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ELDER PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.